Company: NDRA
Filing Date: 2025-04-07
Form Type: 10-K/A
Source: 0001654954-25-003937
Chunk: 31

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-04-07
Form: 10-K/A
Chunk 31
---
onomy Extension Definition Linkbase                                                                           | x |      |       |          |
| 101.LAB | XBRL Taxonomy Extension Label Linkbase                                                                                | x |      |       |          |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase                                                                         | x |      |       |          |

________________

* Indicates management compensatory plan, contract or arrangement.

| 5 |

<div align='center'>SIGNATURES</div>

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| Dated: April 4, 2025 | ENDRA Life Sciences Inc. 
 By:                      | /s/ Alexander Tokman                                                                        |
|:---------------------|:-------------------------|:--------------------------------------------------------------------------------------------|
|                      |                          | Alexander Tokman                                                                            |
|                      |                          | Chief Executive Officer and Chairman of the Board of Directors(Principal Executive Officer) |

| 6 |